Biodegradable poly(lactic acid) and poly(lactide-co-glycolide) microcapsules: problems associated with preparative techniques and release properties.
暂无分享,去创建一个
[1] R. Jalil,et al. Microencapsulation using poly(DL-lactic acid). III: Effect of polymer molecular weight on the release kinetics. , 1990, Journal of microencapsulation.
[2] R. Jalil,et al. Microencapsulation using poly(DL-lactic acid). I: Effect of preparative variables on the microcapsule characteristics and release kinetics. , 1990, Journal of microencapsulation.
[3] R. Jalil,et al. Microencapsulation using poly (L-lactic acid) II: Preparative variables affecting microcapsule properties. , 1990, Journal of microencapsulation.
[4] R. Jalil,et al. Microencapsulation using poly (L-lactic acid) III: Effect of polymer molecular weight on the microcapsule properties. , 1990, Journal of microencapsulation.
[5] R. Jalil,et al. Microencapsulation using poly(L-lactic acid) IV: Release properties of microcapsules containing phenobarbitone. , 1990, Journal of microencapsulation.
[6] R. Jalil,et al. Microencapsulation using poly(L-lactic acid). I: Microcapsule properties affected by the preparative technique. , 1989, Journal of microencapsulation.
[7] H. Okada,et al. Controlled Release of LHRH Agonist, Leuprolide Acetate, from Microcapsules: Serum Drug Level Profiles and Pharmacological Effects in Animals , 1989, The Journal of pharmacy and pharmacology.
[8] R. Bodmeier,et al. The effect of the addition of low molecular weight poly(dl-lactide) on drug release from biodegradable poly(dl-lactide) drug delivery systems , 1989 .
[9] J. Benoit,et al. Microencapsulation of peptide: a study of the phase separation of poly(d,l-lactic acid-co-glycolic acid) copolymers 50/50 by silicone oil , 1989 .
[10] R. Bodmeier,et al. Preparation of Biodegradable Poly(±)lactide Microparticles Using a Spray‐Drying Technique , 1988, The Journal of pharmacy and pharmacology.
[11] H. Okada,et al. In vivo release profiles of leuprolide acetate from microcapsules prepared with polylactic acids or copoly(lactic/glycolic) acids and in vivo degradation of these polymers. , 1988, Chemical & pharmaceutical bulletin.
[12] H. Okada,et al. Controlled-release of leuprolide acetate from polylactic acid or copoly(lactic/glycolic) acid microcapsules: influence of molecular weight and copolymer ratio of polymer. , 1988, Chemical & pharmaceutical bulletin.
[13] C. Malanga,et al. A method for the preparation of polylactic acid microcapsules of controlled particle size and drug loading. , 1988, Journal of microencapsulation.
[14] T Yashiki,et al. A new technique to efficiently entrap leuprolide acetate into microcapsules of polylactic acid or copoly(lactic/glycolic) acid. , 1988, Chemical & pharmaceutical bulletin.
[15] N. Leelarasamee,et al. Effect of surface active agents on drug release from polylactic acid-hydrocortisone microcapsules. , 1988, Journal of microencapsulation.
[16] R. Bodmeier,et al. Polylactic acid microspheres containing quinidine base and quinidine sulphate prepared by the solvent evaporation method. III. Morphology of the microspheres during dissolution studies. , 1988, Journal of microencapsulation.
[17] T. Chang,et al. Control release of prostaglandin E2 from polylactic acid microcapsules, microparticles and modified microparticles. , 1988, Journal of microencapsulation.
[18] H. V. Maulding. Prolonged delivery of peptides by microcapsules , 1987 .
[19] R. Bodmeier,et al. Polylactic acid microspheres containing quinidine base and quinidine sulphate prepared by the solvent evaporation technique. I. Methods and morphology. , 1987, Journal of microencapsulation.
[20] R. Bodmeier,et al. Polylactic acid microspheres containing quinidine base and quinidine sulphate prepared by the solvent evaporation technique. II. Some process parameters influencing the preparation and properties of microspheres. , 1987, Journal of microencapsulation.
[21] G. E. Visscher,et al. Enhancing Drug Release from Polylactide Microspheres by Using Base in the Microencapsulation Process , 1987 .
[22] F. Hutchinson,et al. Biodegradable carriers for the sustained release of polypeptides , 1987 .
[23] J. Benoit,et al. Formation and characterization of cisplatin loaded poly(d,l-lactide) microspheres for chemoembolization. , 1986, Journal of pharmaceutical sciences.
[24] Alan Smith,et al. Evaluation of poly(lactic acid) as a biodegradable drug delivery system for parenteral administration , 1986 .
[25] G. E. Visscher,et al. Biodegradation of and tissue reaction to poly(DL-lactide) microcapsules. , 1986, Journal of biomedical materials research.
[26] J. Benoit,et al. A physicochemical study of the morphology of progesterone-loaded poly (d,l-lactide) microspheres , 1986 .
[27] C. Thies,et al. The formation and characterization of hydrocortisone‐loaded poly((±)‐lactide) microspheres , 1986, The Journal of pharmacy and pharmacology.
[28] H. V. Maulding,et al. Evaluation of biodegradable microspheres prepared by a solvent evaporation process using sodium oleate as emulsifier , 1986 .
[29] T. Tice,et al. Biodegradable microcapsules: Acceleration of polymeric excipient hydrolytic rate by incorporation of a basic medicament , 1986 .
[30] T. Hogan,et al. Preparation and in vitro evaluation of polylactic acid-mitomycin C microcapsules. , 1986, Journal of microencapsulation.
[31] T. Kondo,et al. Mechanism of hydrolytic degradation of poly(L-lactide) microcapsules: effects of pH, ionic strength and buffer concentration. , 1986, Journal of microencapsulation.
[32] T. Hogan,et al. Kinetics of drug release from polylactic acid-hydrocortisone microcapsules. , 1986, Journal of microencapsulation.
[33] P. Rohdewald,et al. Polylactic acid nanoparticles, a colloidal drug delivery system for lipophilic drugs , 1985 .
[34] T. Tice,et al. Preparation of injectable controlled-release microcapsules by a solvent-evaporation process , 1985 .
[35] L. M. Sanders,et al. Controlled delivery of an LHRH analogue from biodegradable injectable microspheres , 1985 .
[36] J. Cummings,et al. In vitro release of adriamycin from drug-loaded albumin and haemoglobin microspheres. , 1985, Journal of microencapsulation.
[37] M. Nakano,et al. Control of release rate of bleomycin from polylactic acid microspheres by additives. , 1985, Chemical & pharmaceutical bulletin.
[38] C. Chu. Degradation phenomena of two linear aliphatic polyester fibres used in medicine and surgery , 1985 .
[39] T. Kondo,et al. Preparation and in vitro degradation properties of polylactide microcapsules. , 1985, Chemical & pharmaceutical bulletin.
[40] H. Klemcke,et al. Prolonged suppression of plasma LH levels in male rats after a single injection of an LH-RH agonist in poly(DL-lactide-co-glycolide) microcapsules. , 1985, Journal of andrology.
[41] G E Visscher,et al. Biodegradation of and tissue reaction to 50:50 poly(DL-lactide-co-glycolide) microcapsules. , 1985, Journal of biomedical materials research.
[42] M. Nakano,et al. Preparation and evaluation in vitro and in vivo of polylactic acid microspheres containing doxorubicin. , 1982, Chemical & pharmaceutical bulletin.
[43] C. Rostron,et al. The preparation and characterization of poly(D,L-lactic acid) for use as a biodegradable drug carrier. , 1985, Pharmaceutica acta Helvetiae.
[44] D. Wise,et al. Poly(lactic/glycolic acid) biodegradable drug-polymer matrix systems. , 1985, Methods in enzymology.
[45] T. Tice,et al. Poly(lactide-co-glycolide) microcapsules for controlled release of steroids. , 1985, Methods in enzymology.
[46] S. Pepeljnjak,et al. The in vivo evaluation of poly(lactic acid) microcapsules of pilocarpine hydrochloride. , 1985, Journal of microencapsulation.
[47] J. C. Price,et al. Microencapsulation and dissolution properties of a neuroleptic in a biodegradable polymer, poly(d,l-lactide). , 1985, Journal of pharmaceutical sciences.
[48] J. Benoit,et al. Characterization of drug-loaded poly(d,l-lactide) microspheres. , 1984, Journal of pharmaceutical sciences.
[49] D. Lewis,et al. Controlled release of a luteinizing hormone-releasing hormone analogue from poly(d,l-lactide-co-glycolide) microspheres. , 1984, Journal of pharmaceutical sciences.
[50] S. Davis,et al. Preparation and evaluation of biodegradable polymeric systems for the intra‐articular delivery of drugs , 1984, The Journal of pharmacy and pharmacology.
[51] P. B. Deasy,et al. Microencapsulation and related drug processes , 1984 .
[52] I. Jalšenjak,et al. Poly(lactic acid) microencapsulated oxytetracycline: in vitro and in vivo evaluation. , 1984, Journal of microencapsulation.
[53] T. Kondo,et al. A new method of preparing monocored water-loaded microcapsules using interfacial polymer deposition process. , 1984, Journal of microencapsulation.
[54] L. R. Beck,et al. Clinical evaluation of an improved injectable microcapsule contraceptive system. , 1983, American journal of obstetrics and gynecology.
[55] M. Goosen,et al. Long-acting Insulin: Slow Release of Insulin from a Biodegradable Matrix Implanted in Diabetic Rats , 1983, Diabetes.
[56] D. Lewis,et al. Poly(DL-lactide-co-glycolide)/norethisterone microcapsules: an injectable biodegradable contraceptive. , 1983, Biology of reproduction.
[57] M. Nakano,et al. Influence of physicochemical properties of polylactic acid on the characteristics and in vitro release patterns of polylactic acid microspheres containing local anesthetics. , 1982, Chemical & pharmaceutical bulletin.
[58] B. Sears,et al. Experimental methods in cancer therapeutics. , 1982, Journal of pharmaceutical sciences.
[59] M. Nakano,et al. Preparation and evaluation in vitro of polylactic acid microspheres containing local anesthetics. , 1981, Chemical & pharmaceutical bulletin.
[60] J. Anderson,et al. The role of the fibrous capsule in the function of implanted drug-polymer sustained release systems. , 1981, Journal of biomedical materials research.
[61] D. Lewis,et al. Clinical evaluation of injectable biodegradable contraceptive system. , 1981, American journal of obstetrics and gynecology.
[62] K. Sugibayashi,et al. Drug-carrier property of albumin microspheres in chemotherapy. V. Antitumor effect of microsphere-entrapped adriamycin on liver metastasis of AH 7974 cells in rats. , 1981, Chemical & pharmaceutical bulletin.
[63] Yoshioka Toshio,et al. Specific delivery of mitomycin c to the liver, spleen and lung: Nano- and m1crospherical carriers of gelatin , 1981 .
[64] N. Peppas,et al. Development of Biodegradable and Injectable Latices for Controlled Release of Potent Drugs , 1981 .
[65] K. Widder,et al. In vitro release of biologically active adriamycin by magnetically responsive albumin microspheres. , 1980, Cancer research.
[66] D. Wise,et al. Long‐term controlled delivery of levonorgestrel in rats by means of small biodegradable cylinders , 1980, The Journal of pharmacy and pharmacology.
[67] Nakano Masahiro,et al. Sustained urinary excretion of sulfamethizole following oral administration of enteric coated microcapsules in humans , 1980 .
[68] Ross R. Muth,et al. Biodegradable polymers for use in surgery—polyglycolic/poly(actic acid) homo- and copolymers: 1 , 1979 .
[69] A. Schindler,et al. Sustained drug delivery systems II: Factors affecting release rates from poly(epsilon-caprolactone) and related biodegradable polyesters. , 1979, Journal of pharmaceutical sciences.
[70] J. W. Gibson,et al. New long-acting injectable microcapsule contraceptive system. , 1979, American journal of obstetrics and gynecology.
[71] H. Gabelnick,et al. Biodegradable systems for the sustained release of fertility-regulating agents. , 1979, Journal of steroid biochemistry.
[72] A. Schindler,et al. Sustained drug delivery systems. I. The permeability of poly(ϵ-caprolactone), poly(DL-lactic acid), and their copolymers , 1979 .
[73] T. Epperly,et al. A new long-acting injectable microcapsule system for the administration of progesterone. , 1979, Fertility and sterility.
[74] K. Widder,et al. Magnetic microspheres: synthesis of a novel parenteral drug carrier. , 1979, Journal of pharmaceutical sciences.
[75] D. Wise,et al. Sustained release of sulphadiazine , 1978, The Journal of pharmacy and pharmacology.
[76] J M Brady,et al. Degradation rates of oral resorbable implants (polylactates and polyglycolates): rate modification with changes in PLA/PGA copolymer ratios. , 1977, Journal of biomedical materials research.
[77] G. Wilkes,et al. Some mechanical property considerations of reconstituted collagen for drug release supports. , 1977, Biomaterials, medical devices, and artificial organs.
[78] F. Boettner,et al. Controlled release of biologically active drugs. , 1976, Bulletin of the Parenteral Drug Association.
[79] D. Wise,et al. Sustained release of an antimalarial drug using a copolymer of glycolic/lactic acid. , 1976, Life sciences.
[80] C. Thies. Characterization of Microcapsules Containing Naltrexone or Naltrexone Pamoate , 1976 .
[81] T. Cicero,et al. In vivo and in vitro evaluation of a microencapsulated narcotic antagonist. , 1976, Journal of pharmaceutical sciences.
[82] S. Yolles,et al. Long acting delivery systems for narcotic antagonists II: release rates of naltrexone from poly(lactic acid) composites. , 1975, Journal of pharmaceutical sciences.
[83] S. Yolles,et al. Timed-release depot for anticancer agents. , 1975, Journal of pharmaceutical sciences.
[84] R. A. Miller,et al. Single dose, long duration, subcutaneous drug administration. , 1975, Journal of oral medicine.
[85] W. Wardell. Clinical Pharmacology at University Medical Centers. I. Functions and Organization , 1974, Journal of clinical pharmacology.
[86] W. J. Larson,et al. Degradation rates of polymers and copolymers of polylactic and polyglycolic acids. , 1974, Oral surgery, oral medicine, and oral pathology.
[87] D. Wise,et al. POLYLACTIC ACID AS A BIODEGRADABLE CARRIER FOR CONTRACEPTIVE STEROIDS , 1973 .
[88] T. Miyata,et al. Collagen as a Vehicle for Drug Delivery , 1973 .
[89] J M Brady,et al. Resorption rate, route, route of elimination, and ultrastructure of the implant site of polylactic acid in the abdominal wall of the rat. , 1973, Journal of biomedical materials research.
[90] D. E. Cutright,et al. Histologic comparison of polylactic and polyglycolic acid sutures. , 1971, Oral surgery, oral medicine, and oral pathology.
[91] S. D. Bruck. Sterilization problems of synthetic biocompatible materials. , 1971, Journal of biomedical materials research.
[92] F Leonard,et al. Biodegradable poly(lactic acid) polymers. , 1971, Journal of biomedical materials research.
[93] H. Tatum. Fertility control and acceptability in women of contraceptive steroids released in microquantities from subcutaneous silastic capsules , 1970 .
[94] H. Wagner,et al. Preparation of metabolizable radioactive human serum albumin microspheres for studies of the circulation. , 1970, The International journal of applied radiation and isotopes.
[95] K C Pani,et al. Polylactic acid for surgical implants , 1966, Archives of surgery.
[96] W I Higuchi,et al. Investigation of factors influencing release of solid drug dispersed in inert matrices. , 1966, Journal of pharmaceutical sciences.
[97] J. Folkman,et al. THE USE OF SILICONE RUBBER AS A CARRIER FOR PROLONGED DRUG THERAPY. , 1964, The Journal of surgical research.
[98] T. Higuchi. MECHANISM OF SUSTAINED-ACTION MEDICATION. THEORETICAL ANALYSIS OF RATE OF RELEASE OF SOLID DRUGS DISPERSED IN SOLID MATRICES. , 1963, Journal of pharmaceutical sciences.
[99] T. Higuchi,et al. Rate of release of medicaments from ointment bases containing drugs in suspension. , 1961, Journal of pharmaceutical sciences.